Rising Demand for Natural Supplements Fuels White Kidney Bean PE Market According to a newly published market research report by 24LifeSciences, global White Kidney Bean PE market was valued at USD 41.8 million in 2024 and is projected to reach USD 64.2 million by 2032, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025–2032. White Kidney Bean PE (Phaseolus vulgaris extract), standardized to contain the active compound Phaseolamin, is a potent alpha-amylase inhibitor widely utilized as a natural starch blocker in nutritional supplements and functional foods. Its primary mechanism involves inhibiting the enzyme responsible for breaking down complex carbohydrates into simple sugars, thereby reducing carbohydrate absorption and caloric intake. This scientifically supported functionality underpins its established role in weight management formulations and blood sugar control supplements, making it a cornerstone ingredient in the global preventative health and wellness market. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/12197/white-kidney-bean-pe-market